chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Large swelling around vaccination site, hot painful, hardened. Swelling started day after injection, increasing for two days. Mother stated swelling is reduced today (1-31-03). Took child to doctor who prescribed an antibiotic for another unrelated illness - asthma.
Information has been received from a registered nurse concerning a 15 year old female with seafood allergy, no known drug allergies and no pertinent medical history who on 22-SEP-2009 was vaccinated intramuscularly into left arm with the second 0.5mL dose of GARDASIL (LOT# 658271/0558X). The patient did not have a reaction after the first dose of GARDASIL which was given on 23-JUL-2009. On 23-SEP-2009, the patient's mother reported (via a phone message) that her daughter had hives. The patient sought an unspecified medical attention. The patient was not recovered at this time of the report. Additional information has been requested.
Patient completed 15 minute observation and left to return to work.  Patient came back to vaccination area between 5:45 AM and 6:00 AM with dizziness.  He was instructed to sit down, and was offered food and water.  Patient agreed to water.  Symptoms gradually improved over a period of approximately 30 minutes.  Patient returned to work after recovering.
PT HAD BILAT MATECTOMY D/T CANCER, REQUESTED INJECTION TO BE GIVEN IN  THIGH. VACCINE WAS GIVEN IN R THIGH PER REQUEST.
Scattered areas of urticaria (hives) spreading diffusely over body. Some areas of vasculitis on arms and legs. Symptoms began within 24 hours of vaccine and have continued until present date. Prednisone prescription given on February 18th and taken for 9 days as prescribed (20MG- 3 tabs x 3 days, 2 tabs x 3 days, 1 tab x 3 days) taken with Benadryl as advised. Symptoms continued. Urgent care visit on February 3rd.  Treated with methylPREDNISolone sod suc(PF) (SOLU-medrol) Injection 125 mg and prescribed predniSONE (DELTASONE) 20 MG tablet and famotidine (PEPCID) 40 MG tablet. Following injection skin is moderately less irritated.
Fever100º + Body and muscle pain specially the rib cage Headache Chills Tiredness Nausea
Patient had first vaccine 12/18/2020, second vaccine 1/8/2021. Previously healthy female had deteriorating vision and eye doctor recommended she be screened for diabetes. A1c was approximately 10% despite healthy weight and diet. Lab results 6/20/22 confirmed presence of insulin antibodies (patient never treated with insulin). I have read case reports of new onset type 1 diabetes 4-8 post COVID vaccination and she is presenting the same way.
Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and CHILLS (Chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced HEADACHE (Headache) and CHILLS (Chills). At the time of the report, HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.
She got her 4th booster at home (homebound).  She got the vaccine on Tuesday late afternoon. To her knowledge and recollection she had no reaction to that.  On Wednesday a CNA came as they always do, she slept OK that evening.  She know that the nurse came and changed some dressings on her stomach.  She does not remember her coming, but knows it happened, and apparently she just went to sleep after eating breakfast and then does not remember that or what she ate.  She apparently fell asleep after the nurse left.  She then woke up and it was dark and remembers it was 1:00 AM Thursday and had lost the entire previous day.  Her roommates thought she was dying and told her that as she did not respond and would not wake up.  She has been OK since waking up on Thursday.
3 days after receiving influenza vaccine had pain in hands and left knee and ankle (left). Since then has spread to all joint discomfort. Taking tylenol arthritis formula per MD. To follow-up with this or if no improvement for blood work. Family history of rheumatoid Arthritis. He has no previous symptoms 12/27 still with symptoms
pt exp hives, swollen w/in 24 hr on hands, feet,lips; tx w/Benadryl; w/in 12 hr pt covered w/ sever welts;per mtr pt recv shot of Prednisone, Benadryl;temp of 101;sx persisted until 12/16/1996
Information has been received from a Registered Nurse (R.N.) concerning a female patient (age unknown) who was vaccinated with a dose of Gardasil. The patient fainted after receiving the Gardasil. Unspecified medical attention was sought, the patient recovered. The reporter reported that two other patient experienced fainting after receiving the dose of Gardasil. Additional information has been requested.
Episodes of shortness of breadth/ difficulty breathing; Chest Pain; Elevated d-dimer values; This is a spontaneous report from a contactable consumer (patient). This 38-year-old, nonpregnant, female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) dose 1 at a hospital facility, via an unspecified route of administration, administered in left arm on 13Apr2021 09:30 AM (age at the time of vaccination: 38 years; Batch/Lot Number: EW0151) as single dose for COVID-19 immunization. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19 and since the vaccination patient had not been tested for COVID-19. Patient had no known allergies and no medical history. The patient's concomitant medications were not reported. The patient experienced episodes of shortness of breath, chest pain, elevated D-dimer values, difficulty breathing, multiple ER visits starting "23Mar2021" at 09:45 AM. The adverse events did result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient reported her events were not serious, did not have hospitalization, and were not disabling/incapacitating. No treatment was given for the events. Patient was not recovered from shortness of breath, chest pain, elevated D-dimer values, and difficulty breathing.
had a rash again and had to get intramuscular steroid injections in her butt again after the second dose; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: 041C21A, Expiration date: Not reported), via an unspecified route of administration on 08Sep2021 as dose 2, single for COVID-19 immunization. Medical history included infertility issues. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: 041C2A, Expiration date: Not reported), via an unspecified route of administration on 11Aug2021 as dose 1, single for COVID-19 immunization and experienced terrible rash/rash was blistering, heart palpitations, migraine, open sores on her body and had scar tissues on her arms. She had been in and out of emergency rooms (ER) getting steroid injections in her butt and had to be on high doses of steroid pills. The patient had to get her second dose on 08Sep2021 to be compliant for school. She had just been tapered off the her steroids prior to the second dose and then she erupted everywhere and had a rash again in Sep2021 and had to get intramuscular steroid injections in her butt again after the second dose. This is the most severe reaction that her doctor has seen until now. She was put on a higher dose of steroids, oral diphenhydramine (BENADRYL) and an oral histamine receptor blocker called famotidine (PEPCID). She wants to go through invetro and she cannot proceed with invetro due to the high dose of steroids, she had infertility issues and she cannot continue with stemming procedure for infertility issues since the vaccine messed her up so bad. She's concerned that it's going to affect her fertility. She wants to have a baby and she cannot try to have a baby due to her high dose of steroids. On an unspecified date, the patient shingle's test was negative. The patient wanted to know that how long these events last. The outcome of event was unknown at the time of report.  No follow-up attempts are possible. No further information is expected.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 12/20/21pfizer,Lot#EK5730 2nd dose: 01/10/21Pfizer,Lot# EL3248 Diagnosed covid positive:07/28/2021 Symptom onset:07/28/2021 Exposure:Home  Symptoms:fever,fatigue,muscle aches, sore throat,runny nose
Headaches, dizziness, lightheaded after standing up, shortness of breath, high blood pressure, fatigue, brain fog, chest pain
This spontaneous report was received from a nurse. The nurse stated that a box of PEDVAXHIB lot # L012835, exp. 11-MAR-2018 was inadvertently stored in the freezer because the box of PEDVAXHIB "looks just like M-M-R II". This happened due to human error. No patient received any doses of PEDVAXHIB. No adverse effects to report. No additional information was provided. No Product Quality Complaint (PQC). Additional information has been requested.
Patient experiencing tingling in mouth and throat. No SOB or chest pain. Provider assessed and ordered 25mg Benadryl IM. Administered. Two subsequent vitals taken. Patient feeling much better. Observed for additional 30 minutes. Provider reassessed and patient discharge home with mother
Mom called to describe increased fussiness and irritability 12-18 post vax. The child was not usually a fussy baby. Sleeping was decreased and the pt was afebrile.
low b/p coupled dizziness; Hx of Cerebral infarct; numbness to limbs Age 89     Note: Resident came back from the emergency department at  medical center at 1:45.The resident is alert and oriented. The resident has been diagnosed, with deconditions, paresthesia, and gait instability. CT of the head was reassuring. No significant labs or EKG abnormalities noted. No new medications order received.
This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 31-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: BIN - 201), via an unspecified route of administration (at the age of 31-years), administered in arm left on 25Mar2021 at 12:00 as dose 1, single for COVID-19 immunization. Medical history included covid-19 and none from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. The most recent COVID-19 vaccine was administered in pharmacy or drug store. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On an unspecified date, the patient experienced terrible smell with most all foods, terrible taste similar to the smell. On 28Mar2021, experienced sore arm moving into armpit and cough. It was further stated that terrible smell with most all foods lingering terrible taste similar to the smell , sore arm moving into armpit day 3, day 3 feels like I am beginning to get a cough. The treatment was not received for all the events. The clinical outcome for the events was reported as not recovered.  No follow-up attempts are needed. No further information is expected.
One of twenty-one cases:  A nonserious, spontaneous event of a half dose of FLUMIST administered was received from a registered nurse.  The event occurred in an eighth grade, adolescent female.  No medical or drug history was reported for this adolescent.  FLUMIST was inadvertently administered in one nostril to 21 children during a flu clinic at an elementary school.  The nurse administering the doses had been trained on administering FLUMIST but forgot to take off the divider clip;  21 children received only half a dose.  No adverse effects were reported; the event is considered resolved.
Fevers to 104.4 12/12 -> 12/14 8 AM Temp 99.1 12/14 at 10 AM.
received Varivax #1 on 7/24/2023 and on the morning of 7/25/2023 noted to have redness 7cm X 10cm left backside of arm and swelling.  APRN will prescribe Keflex.
Fever developed at 8am, Headache began at 12pm, Debilitating migraine by 2pm.  Not responsive to OTC medication (tried Tylenol, Advil, sinus medication),  ice, self cranio-facial massage, water, xanax, & caffeine.    The fire alarm in the kitchen went off at 7pm and the surge of adrenaline (although painful in the moment) resolved the head pain within 3 minutes.
Pt got covid vaccine today and called an hour later to report that she started feeling dizziness, nauseous, and face tightness tingling sensation from nose down. Called nurse and was advised to tell patient to go to the ER. 03/24/2021 04:41:23 PM following up with pt called states she hasn't went to ER, was advised by family to sit down and rest to see if ss improved. Pt did that due to family stating they had similar ss after receiving the 2nd covid dose. Pt states ss are getting better now just having a headache, and still feeling nauseous. Pt just took some tylenol. Advised again to f/u to er she refused. I did advise her if ss didn't improve or happen to worsen then to f/u with er she gave verbal understanding. I also let her know that we would call her again in the next couple of hours to f/u and see how she was doing again. she agreed.03/24/2021 06:51:28 PM. Called Pt to check on her. She stated she is feeling very weak, slight headache and chills, accompanied by neck pain. She states her temperature is normal and she fell asleep for about an hour but woke up shivering. I advised pt that she can still go to ER and if symptoms worsen she needs to go be evaluated. Pt stated she told her husband that if she began to feel worse she would go to the ER. I advised pt that I would call in the morning to check on her again.   03/25/2021 09:20:21 AM > called pt to check on her, pt stated she ended up going to Patients ER last night and was given a "banana bag" and morphine for the head and neck pain. The ER kept her for a few hours and released her to go home and rest. Pt stated she is feeling much better today and expressed thanks for checking on her.    03/25/2021 01:50:18 PM. Ariel this is the pt that had a reaction 1 hour after getting vaccine in. Pt had reaction set in after leaving the facility. Please advise.   03/25/2021 02:06:38 PM > Spoke to Dr, please do an incident report. Then I will report to VAERS, thank you!
pt recv vax 9OCT95 & devel redness & warmth @ the inj site;no tx necessary;pt recovered;
Patient was administered dose 1 in her right arm more than 6 hours after first vial puncture; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered dose 1 in her right arm more than 6 hours after first vial puncture) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered dose 1 in her right arm more than 6 hours after first vial puncture). On 15-Mar-2021, EXPIRED PRODUCT ADMINISTERED (Patient was administered dose 1 in her right arm more than 6 hours after first vial puncture) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products were not reported.  Treatment medications were not provided by the reporter.
an improperly stored dose of PROQUAD was administered to a patient; No additional adverse effects reported.; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patients' pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant medications were not reported.  On 29-MAY-2020, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD)  injection (route of administration, dosage regimen and anatomical location were not reported, lot number S031702, which has been verified to be valid, expiration date reported and validated on 06-APR-2021) as prophylaxis (product storage error).  The vaccine was stored at a temperature of 32.7 degrees Fahrenheit (F) for a timeframe of 4 hours, as record by data logger. No previous temperature excursion was reported. No adverse effects were reported.
pt started breaking out in rash around 3pm white raised bumps w large red areas surrounding.fever 104 chills pain in rt arm pain in both arms wrists legs & hips eve day of vax 3/30. 4/7 still running fever & pain. symptom free 4/16
Patient passed out the next day after receiving hid vaccine while shopping.  He had sharp chest pain under the rib cage. He stated that it felt as though he was being stabbed on his right side. He was brought to the hospital from via ambulance.
Presented to the ED with syncope and found to have bradycardia with sick sinus syndrome with recurrent pauses >5 seconds while awake. Permanent pacemaker placed  # Sinus pauses # Troponin elevation # Incomplete RBBB - resolved 7s pause during sleep then 17s pause during blood draw.  Syncope with 17s pause, emesis afterwards. Second event was possibly related to an exaggerated vagal response. Incomplete RBBB noted on second EKG 9/14 AM, sinus brady on repeat after recent pause 9/15 AM. Troponin elevated on admission but stabilized, repeat after sinus pause remains stable. Not nodal blockers at home. No recent illness, chest pain or typical EKG changes or pericardial effusion on prelim echo to suggest myopericarditis. No history of infiltrative disease, normal real function.
Fainted and fell from chair hitting face on floor causing abrasions. Showed seizure like activity. Was incontinent of urine. Pale color. Paramedics called. Oxygen and IV started. Transported to  Hospital.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021 at 9:16 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 37.59.  Concomitant products were not provided.  On 15-Apr-2021, Excursion time was 09 AM temperature was 34 respectively total doses given for the day was 188, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 06-Apr-2021, vial was moved to clinic on 15-Apr-2021. 18 vials were sent to clinic. Vaccine BUD date was 09-May-2021.  On 15-Apr-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 34, 10 AM: 36, 11 AM: 38, 12 PM: 39, 1PM: 43, 2 PM: 44, 3 PM: 44, 4 PM: 42 and 5 PM: 42.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a  traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The  explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Fever, hives, itchy on front/back torso, between legs (thighs), on hands and arms - front/back, on feet on bottom of feet.
Pt exp nausea, vomiting, & diarrhea 1 wk p/receiving Influenza virus; On f/u, reporter stated pt had a gastrointestinal virus that was not related to the Influenza vax;
Information has been received from a physician concerning an 18 year old female with histiocytosis X and severe scoliosis and a history of iron deficiency secondary to dysfunctional uterine bleeding who in August 2007, was vaccinated with a first dose of GARDASIL vaccine (yeast) (lot number, injection site and route not reported). On an unspecified date, the patient was vaccinated with a second dose of GARDASIL vaccine (yeast) (lot number, injection site and route not reported). In March 2008, the patient was vaccinated with a third dose of GARDASIL vaccine (yeast) (lot number, injection site and route not reported). About the time she started the vaccination, the patient was very ataxic. At the time of reporting, the patient's speech was slurred and slow, and was hyper reflexic with present Babinskis bilaterally. The patient was seen by a neurologist, but had no diagnosis. The patient had scheduled for second opinion neurologist. Additional information has been requested.  This is in follow-up to report(s) previously submitted on 8/14/2008. Information has been received from a physician concerning an 18 year old female with histiocytosis X and severe scoliosis and a history of iron deficiency secondary to dysfunctional uterine bleeding who in September 2007, was vaccinated with a first dose of GARDASIL (lot number, injection site and route not reported). On an unspeciifed date, the patient was vaccinated with a second dose of GARDASIL (lot number, injection site and route not reported). In March 2008, the patient was vaccinated with a third 0.5 ml dose of GARDASIL (lot number, injection site and route not reported). About the time she started the vaccination, the patient was very ataxic. At the time of reporting, the patient's speech was slurred and slow, and was hyper reflexic with present Babinskis bilaterally. The patient was seen by a neurologist, but had no diagnosis. The patient had scheduled for second opinion neurologist. At the time of this report, the patient's events persisted. This is a consolidation of two reports concerning the same patient. Additional information has been requested.